MarketCap
Facebook
X
TelegramOxford Immunotec Global PLC DPO Ratio 2011-2026 | OXFD
Annual DPO Ratio Oxford Immunotec Global PLC
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| - | 45.8 | 60.8 | 53.4 | 29.6 | 46.9 | 36 | 45.3 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 60.8 | 29.6 | 45.4 |
DPO Ratio of other stocks in the Diagnostics research industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
120 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Bioventus
BVS
|
35.1 | $ 9.12 | 1.33 % | $ 608 M |  USA |
 |
Biomerica
BMRA
|
32.4 | $ 2.12 | -0.47 % | $ 4.87 M | USA |
 |
Fulgent Genetics
FLGT
|
34.9 | $ 16.37 | 0.24 % | $ 495 M | USA |
|
Akumin
AKU
|
21.3 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Enzo Biochem
ENZ
|
52.3 | - | -8.98 % | $ 14.8 K | USA |
 |
Lantheus Holdings
LNTH
|
23.6 | $ 75.01 | -0.96 % | $ 5.06 B | USA |
 |
Medpace Holdings
MEDP
|
13.3 | $ 460.9 | 0.87 % | $ 13.3 B | USA |
 |
Myriad Genetics
MYGN
|
45.9 | $ 4.77 | 2.36 % | $ 442 M | USA |
 |
National Research Corporation
NRC
|
10.1 | $ 17.42 | -0.51 % | $ 390 M | USA |
 |
DermTech
DMTK
|
47.4 | - | -11.32 % | $ 2.94 M | USA |
 |
Aspira Women's Health
AWH
|
112 | - | -6.19 % | $ 10.5 M | USA |
 |
Pacific Biosciences of California
PACB
|
59.7 | $ 1.39 | -0.36 % | $ 417 M | USA |
 |
Co-Diagnostics
CODX
|
106 | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Accelerate Diagnostics
AXDX
|
125 | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
17.7 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
61.4 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
780 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
43.5 | - | 0.12 % | $ 80.1 M | China |
 |
Precipio
PRPO
|
53 | $ 26.85 | -0.3 % | $ 34.8 M | USA |
 |
Personalis
PSNL
|
67.3 | $ 7.7 | 1.18 % | $ 456 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
8.98 | - | - | $ 10.7 B | USA |
 |
RadNet
RDNT
|
23.5 | $ 60.0 | -2.83 % | $ 4.51 B | USA |
 |
Charles River Laboratories International
CRL
|
24.5 | $ 159.79 | 1.13 % | $ 7.92 B | USA |
 |
IQVIA Holdings
IQV
|
126 | $ 165.38 | -0.95 % | $ 28.4 B | USA |
 |
Senseonics Holdings
SENS
|
68 | $ 6.74 | 1.81 % | $ 281 M | USA |
 |
Sotera Health Company
SHC
|
46.9 | $ 13.89 | 0.07 % | $ 3.94 B | USA |
 |
Biocept
BIOC
|
56.3 | - | -13.05 % | $ 7.29 M | USA |
 |
Invitae Corporation
NVTA
|
69 | - | - | $ 21.2 M | USA |
 |
BioNano Genomics
BNGO
|
149 | $ 1.24 | -15.07 % | $ 6.75 M | USA |
 |
Neuronetics
STIM
|
51.8 | $ 1.49 | -7.19 % | $ 98.3 M | USA |
 |
Mettler-Toledo International
MTD
|
53.4 | $ 1 256.48 | 1.41 % | $ 25.9 B |  Schweiz |
 |
Interpace Biosciences
IDXG
|
34.4 | $ 1.71 | 0.73 % | $ 7.5 M | USA |
 |
IDEXX Laboratories
IDXX
|
24.9 | $ 574.14 | -0.76 % | $ 46.2 B | USA |
 |
Illumina
ILMN
|
56.3 | $ 125.44 | 1.33 % | $ 19.9 B | USA |
 |
ICON Public Limited Company
ICLR
|
6.52 | $ 101.04 | 0.68 % | $ 8.33 B |  Irlanda |
 |
Guardant Health
GH
|
48.6 | $ 85.0 | 0.05 % | $ 10.7 B | USA |
 |
QIAGEN N.V.
QGEN
|
50 | - | - | $ 10.6 B |  Niderland |
 |
Twist Bioscience Corporation
TWST
|
12.5 | $ 45.99 | 3.35 % | $ 2.75 B | USA |
 |
Chembio Diagnostics
CEMI
|
52.5 | - | 0.22 % | $ 16.8 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
31.5 | $ 265.75 | 0.5 % | $ 22.1 B | USA |
 |
Motus GI Holdings
MOTS
|
1.72 | - | -34.28 % | $ 263 K |  Israel |
 |
ENDRA Life Sciences
NDRA
|
1.65 K | $ 3.36 | -3.45 % | $ 1.8 M | USA |
 |
NeoGenomics
NEO
|
19.7 | $ 8.05 | -0.62 % | $ 1.03 B | USA |
 |
Natera
NTRA
|
17.9 | $ 195.23 | -2.43 % | $ 19.2 B | USA |
 |
CareDx, Inc
CDNA
|
44.2 | $ 17.58 | 0.11 % | $ 937 M | USA |